share_log

港股异动 | 抗疫概念股全线回吐 永胜医疗(01612)挫逾12% 报道称奥密克戎新冠患者只出现轻微症状

Changes in Hong Kong stocks | Anti-epidemic concept stocks are back across the board, Yongsheng Healthcare (01612) fell more than 12%, reports say Omicron COVID-19 patients only showed mild symptoms

智通財經 ·  Nov 30, 2021 11:30

The Zhitong Finance App learned that anti-epidemic concept stocks rebounded across the board in early trading. As of press release, Yongsheng Medical (01612) fell 12.14% to HK$1.23; Kaituo Pharmaceutical-B (09939) fell 5.11% to HK$55.7; Junshi Biotech (01877) fell 4.18% to HK$45.8; and Zhongsheng Pharmaceutical (01177) fell 0.89% to HK$5.59.

According to the news, according to media reports, the president of the South African Medical Association pointed out that the dozens of patients she came into contact with suspected of being infected with the “Omicron” variant of the coronavirus showed only mild symptoms. Currently, they have fully recovered and have not been hospitalized. Kucher said that “omicron” has been hyped as an “extremely dangerous virus variant” with many variants, but in reality the toxicity of the virus is still unknown. But the World Health Organization urges caution.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment